ECP
SPFR.WS

Empyrean Capital Partners’s Jaws Spitfire Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Cl SPFR.WS Stock Holding History

Empyrean Capital Partners’s Portfolio SPFR.WS Stock Details SPFR.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-451,597
Closed -$867K – 231
2021
Q2 		$867K Hold
451,597
– – 0.02% 159
2021
Q1 		$885K Buy
+451,597
New +$1.12M 0.03% 139

Other funds holding SPFR.WS

TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Empyrean Capital Partners's SPFR.WS Position: Q3 2021 in Review

Empyrean Capital Partners sold out of Jaws Spitfire Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Cl (SPFR.WS) in Q3 2021, closing a stake of 451,597 shares — an estimated $867K sold.

Empyrean Capital Partners first reported a position in SPFR.WS in Q1 2021 and held it in 2 quarters. The position peaked at $885K in Q1 2021. 1 fund tracked by Wall St. Rank holds SPFR.WS as of Q3 2021.

  • Empyrean Capital Partners reported no remaining Jaws Spitfire Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Cl position as of Q3 2021 after selling out during the quarter.
  • Empyrean Capital Partners sold 451,597 Jaws Spitfire Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Cl shares in Q3 2021, an estimated $867K.
  • Empyrean Capital Partners first reported a position in Jaws Spitfire Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Cl in Q1 2021 and held it in 2 quarters.
  • Empyrean Capital Partners's Jaws Spitfire Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Cl position peaked at $885K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Jaws Spitfire Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Cl as of Q3 2021.

Based on Empyrean Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.